Skip to Main Content

Author Details

Minyoung Jang
Columbia University Irving Medical Center
2011
15
8
PMIDPaper TitleJournal TitlePublished Year
36868144Cost of pediatric laryngotracheal reconstruction: Differences between single-versus double-stage procedures.Int J Pediatr Otorhinolaryngol2023
37391661Follow-up for a Preterm Infant with Subglottic Stenosis.Neoreviews2023
36868144Cost of pediatric laryngotracheal reconstruction: Differences between single-versus double-stage procedures.Int J Pediatr Otorhinolaryngol2023
37391661Follow-up for a Preterm Infant with Subglottic Stenosis.Neoreviews2023
31756694Injection laryngoplasty in infants with unilateral vocal cord paralysis: A survey of ASPO members.Int J Pediatr Otorhinolaryngol2020
31756694Injection laryngoplasty in infants with unilateral vocal cord paralysis: A survey of ASPO members.Int J Pediatr Otorhinolaryngol2020
29501310Risk factors for laryngeal trauma and granuloma formation in pediatric intubations.Int J Pediatr Otorhinolaryngol2018
30114675Impact of poorly controlled epilepsy in the Republic of Guinea.Seizure2018
29958619Evaluating the impact of translated written discharge instructions for patients with limited English language proficiency.Int J Pediatr Otorhinolaryngol2018
30368392Management and outcomes of pediatric vocal cord paresis in Chiari malformation.Int J Pediatr Otorhinolaryngol2018
29501310Risk factors for laryngeal trauma and granuloma formation in pediatric intubations.Int J Pediatr Otorhinolaryngol2018
29958619Evaluating the impact of translated written discharge instructions for patients with limited English language proficiency.Int J Pediatr Otorhinolaryngol2018
30114675Impact of poorly controlled epilepsy in the Republic of Guinea.Seizure2018
30368392Management and outcomes of pediatric vocal cord paresis in Chiari malformation.Int J Pediatr Otorhinolaryngol2018
28760537Randomized double blind trial of amitriptyline versus placebo in treatment of chronic laryngopharyngeal neuropathy.Am J Otolaryngol2017
28760537Randomized double blind trial of amitriptyline versus placebo in treatment of chronic laryngopharyngeal neuropathy.Am J Otolaryngol2017
28420243Quantifying Medical Student Education and Exposure to Otolaryngology.Ann Otol Rhinol Laryngol2017
28417658Resident Involvement in Professional Otolaryngology Organizations: Current Trends in the United States.Otolaryngol Head Neck Surg2017
28420243Quantifying Medical Student Education and Exposure to Otolaryngology.Ann Otol Rhinol Laryngol2017
28417658Resident Involvement in Professional Otolaryngology Organizations: Current Trends in the United States.Otolaryngol Head Neck Surg2017
27132513TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.Oncogene2016
27132513TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.Oncogene2016
25358612Management of chronic laryngopharyngeal neuropathy in the United States and Europe.Ann Otol Rhinol Laryngol2015
25358612Management of chronic laryngopharyngeal neuropathy in the United States and Europe.Ann Otol Rhinol Laryngol2015
22791234Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.Head Neck2013
22791234Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.Head Neck2013
24069219Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma.PLoS One2013
24069219Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma.PLoS One2013
21750205Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.Clin Cancer Res2011
21750205Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.Clin Cancer Res2011
  • 1 - 30 of 30

Recommended Authors

Victoria X Yu
21611Columbia University Medical Center
Career Start Year 2019
Number of shared co-authors 0
David Garber
New York Medical College
Career Start Year 2016
Number of shared co-authors 0
Jennifer Siu
Seattle Children's Hospital
Career Start Year 2015
Number of shared co-authors 0
Benjamin van der Woerd
University of Southern California
Career Start Year 2015
Number of shared co-authors 0
Yael Bensoussan
University of South Florida Morsani College of Medicine
Career Start Year 2014
Number of shared co-authors 0
Karla O'Dell
Keck School of Medicine, University of Southern California
Career Start Year 2011
Number of shared co-authors 0
Michael I Orestes
Walter Reed National Military Medical Center
Career Start Year 2011
Number of shared co-authors 0
Matthew G Crowson
Otolaryngology-Head and Neck Surgery Harvard Medical School
Career Start Year 2010
Number of shared co-authors 0
Matthew R Naunheim
Otolaryngology-Head and Neck Surgery Harvard Medical School
Career Start Year 2009
Number of shared co-authors 0
Soroush Zaghi
The Breathe Institute
Career Start Year 2008
Number of shared co-authors 0
Ana??s Rameau
Sean Parker Institute for the Voice
Career Start Year 2008
Number of shared co-authors 0
Alexander Gelbard
Vanderbilt University Medical Center
Career Start Year 2006
Number of shared co-authors 0
Nikolaus E Wolter
Hospital for Sick Children, University of Toronto
Career Start Year 2005
Number of shared co-authors 0
Lindsay Reder
Southern California Permanente Medical Group, Kaiser Permanente Baldwin Park
Career Start Year 2004
Number of shared co-authors 0
Paul C Bryson
University of Rochester
Career Start Year 2004
Number of shared co-authors 0
Evan J Propst
The Hospital for Sick Children
Career Start Year 2004
Number of shared co-authors 0
Stacey L Ishman
Cincinnati Children's Hospital Medical Center
Career Start Year 2003
Number of shared co-authors 0
Michael J Pitman
Center for Voice and Swallowing, Columbia University Irving Medical Center
Career Start Year 2002
Number of shared co-authors 0
Matthew T Brigger
Rady Children's Hospital-San Diego
Career Start Year 2002
Number of shared co-authors 0
Jonathan M Bock
Medical College of Wisconsin
Career Start Year 1999
Number of shared co-authors 0
Joshua S Schindler
Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Albert L Merati
University of Washington
Career Start Year 1996
Number of shared co-authors 0
Gregory N Postma
Medical College of Georgia at Augusta University
Career Start Year 1995
Number of shared co-authors 0
Mark S Courey
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 0
Clark A Rosen
University of California San Francisco
Career Start Year 1992
Number of shared co-authors 0
Jennifer Anderson
St. Michael's Hospital, University of Toronto
Career Start Year 1992
Number of shared co-authors 0
Christopher J Hartnick
Harvard Medical School
Career Start Year 1992
Number of shared co-authors 0
David W Roberson
Bayhealth Medical Center
Career Start Year 1986
Number of shared co-authors 0
Kevin Fung
Schulich School of Medicine & Dentistry, Western University, Victoria Hospital
Career Start Year 1983
Number of shared co-authors 0
Michael M Johns
University of Southern California
Career Start Year 1979
Number of shared co-authors 0

Collaborators

Carter Van Waes
National Institute of Deafness and Other Communication Disorders
Co-authored papers 4
Zhong Chen
National Institute on Deafness and Other Communication Disorders
Co-authored papers 3
Xinping Yang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Bin Yan
The University of Hong Kong
Co-authored papers 2
Yansong Bian
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Christina Yau
University of California San Francisco
Co-authored papers 1
Susmita G Ramanand
UT Southwestern Medical Center
Co-authored papers 1
Ming Zhan
Ningbo First Hospital, Zhejiang University
Co-authored papers 1
Austin K Mattox
Howard Hughes Medical Institute
Co-authored papers 1
Christopher C Benz
Buck Institute for Research on Aging
Co-authored papers 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Hai Lu
The Fifth Affiliated Hospital, Sun Yat-sen University
Co-authored papers 1
Hector Viadiu
All India Institute of Medical Sciences
Co-authored papers 1
Emiko Sano
0 SW US Veterans Hospital Road
Co-authored papers 1
Rose-Anne Romano
State University of New York at Buffalo
Co-authored papers 1
Hao Sun
University of Illinois at Urbana-Champaign
Co-authored papers 1
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers 1
Wenming Xiao
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Co-authored papers 1
Lai Wei
Clinical Immunology Section, National Eye Institute
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Sam Ng
University of Adelaide
Co-authored papers 1
Steven K Lee
National Institute on Deafness and Other Communication Disorders
Co-authored papers 1
Han Si
Hubei Engineering Research Center for Bio-enzyme Catalysis, Hubei University
Co-authored papers 1
Satrajit Sinha
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Co-authored papers 1
Daniel J Stein
Brigham and Women's Hospital
Co-authored papers 1
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Release 1.2